TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ATNM

Actinium Pharmaceuticals Inc

Healthcare · Biotechnology

1.20$ +0.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ATNM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-15.73 -14.58 -12.87 -9.69 -5.82 -4.31 -1.78 -1.01 0.36 -1.78 -1.10 -0.79
0.04 0.04 0.05 0.03 0.01 0.08 0.04 0.03 0.03 0.03 0.03 0.03
6.89 5.55 2.66 1.57 0.51 0.26 0.10 0.08 0.12 0.14 0.18 0.29
6.89 2.55 1.09 1.43 0.51 0.26 0.10 0.08 0.12 – – –
1.99 -0.65 1.05 0.81 0.35 -0.26 -0.09 0.08 1.58 -0.12 -0.03 -0.02
0.17 0.04 0.04 0.01 0.03 0.01 0.02 0.01 0.02 0.01 0.00 0.00
-0.20 -0.04 -0.07 -0.17 -0.03 -0.01 -0.02 -0.01 -0.02 -0.01 0.00 0.00
– – – – – 0.00 0.00 – – – – –
16.92 29.73 9.93 8.46 4.80 0.00 0.00 1.72 – – – -0.01
-0.18 -0.22 -0.16 -0.14 0.00 -0.05 -0.04 0.00 0.00 0.00 0.00 0.00
17.22 29.50 9.77 8.46 4.80 3.44 6.28 1.71 0.96 0.56 0.98 -0.01
1.29 14.89 -3.17 -1.40 -1.04 -0.89 4.48 0.69 1.30 -1.23 -0.13 -0.80
-15.90 -14.62 -12.91 -9.70 -5.85 -4.33 -1.80 -1.02 0.34 -1.78 -1.10 -0.79

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?